Filtered By:
Condition: Hemorrhagic Stroke
Infectious Disease: COVID-19
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 1354 results found since Jan 2013.
Impact of COVID-19 on the Volume of Acute Stroke Admissions: A Nationwide Survey in Japan
In conclusion, the acute stroke admission volume declined by 2.51% in 2020 relative to 2019 in Japan, especially during the months of high infection, and in highly infected prefectures. Overwhelmed healthcare systems and infection control practices may have been associated with the decline in the stroke admission volume during the COVID-19 pandemic.PMID:35753763 | DOI:10.2176/jns-nmc.2022-0099
Source: Neurologia Medico-Chirurgica - June 26, 2022 Category: Neurosurgery Authors: Takeshi Yoshimoto Hiroshi Yamagami Nobuyuki Sakai Kazunori Toyoda Yoichiro Hashimoto Teruyuki Hirano Toru Iwama Rei Goto Kazumi Kimura Satoshi Kuroda Yuji Matsumaru Susumu Miyamoto Kuniaki Ogasawara Yasushi Okada Yoshiaki Shiokawa Yasushi Takagi Teiji Tom Source Type: research
Treatments in Ischemic Stroke: Current and Future
Background and Aim: Despite progress made over the last 30 years, stroke is still a leading cause of disability and mortality; likewise, its burden is expected to increase over the next decades, due to population growth and aging. The development of drugs with better safety-efficacy profiles as well as strategies able to improve ischemic stroke management from the pre-hospital setting is needed.Summary: The pathophysiology of ischemic stroke involves multiple pathways resulting in cerebral artery obstruction and brain tissue ischemia. To date, the only approved drug for acute ischemic stroke is intravenous thrombolytic alt...
Source: European Neurology - August 2, 2022 Category: Neurology Source Type: research
Implications of COVID-19 to Stroke Medicine: An Epidemiological and Pathophysiological Perspective
Curr Vasc Pharmacol. 2022;20(4):333-340. doi: 10.2174/1570161120666220428101337.ABSTRACTThe neurological complications of Coronavirus 2019 (COVID-19) including stroke have been documented in the recent literature. COVID-19-related inflammation is suggested to contribute to both a hypercoagulable state and haemorrhagic transformation, including in younger individuals. COVID-19 is associated with a heightened risk of ischaemic stroke. Haemorrhagic stroke in COVID-19 patients is associated with increased morbidity and mortality. Cerebral venous sinus thrombosis (CVST) accounts for <1% of stroke cases in the general populat...
Source: Current Vascular Pharmacology - November 3, 2022 Category: Drugs & Pharmacology Authors: Alan King Karen M Doyle Source Type: research
